VITT and Second Doses of COVID-19 Vaccine

Joanne Lacy, Sue Pavord, Kevin E. Brown*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

25 Citations (Scopus)


Vaccination after VITT Forty persons in whom thrombosis and thrombocytopenia had developed after an initial ChAdOx1 nCoV-19 vaccination were given a second dose of a Covid-19 vaccine, most commonly BNT162b2. None of the patients had a recurrence of thrombosis and thrombocytopenia.

Original languageEnglish
Pages (from-to)95
Number of pages1
JournalNew England Journal of Medicine
Issue number1
Publication statusPublished - 22 Dec 2021

Bibliographical note

Funding Information: No funding information.

Open Access: Free to read, but no Open Access licence. For personal use only. No other uses without permission.

Publisher Copyright: Copyright © 2022 Massachusetts Medical Society. All rights reserved.

Citation: Lacy, Joanne, Sue Pavord, and Kevin E. Brown. "VITT and Second Doses of Covid-19 Vaccine." New England Journal of Medicine 386.1 (2022): 95-95.

DOI: 10.1056/NEJMc2118507


Dive into the research topics of 'VITT and Second Doses of COVID-19 Vaccine'. Together they form a unique fingerprint.

Cite this